This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Clarivate Plc | |
|---|---|
| Name | Clarivate Plc |
| Type | Public limited company |
| Founded | 2016 (as Clarivate Analytics) |
| Predecessor | Thomson Reuters Intellectual Property and Science business |
| Headquarters | London, United Kingdom; Philadelphia, United States |
| Key people | Jerre Stead (Chairman), Jerre Stead, Jonathan A. Gearhart (CEO) |
| Industry | Information services, Intellectual property, Research analytics |
| Products | Web of Science, Derwent Innovation, Cortellis, EndNote, ProQuest |
| Revenue | (see Financial performance and ownership) |
| Num employees | (varies) |
Clarivate Plc is a multinational information services and analytics company providing data, workflow tools, and intellectual property services to researchers, inventors, corporations, universities, and governments. The company grew from heritage assets originating at Institute for Scientific Information and the intellectual property unit of Thomson Reuters, operating global brands such as Web of Science, Derwent, and Cortellis. Clarivate’s products are widely used by institutions including Harvard University, Massachusetts Institute of Technology, National Institutes of Health, European Commission, and major corporations like Pfizer, Samsung, and General Electric.
Clarivate’s lineage traces to the Institute for Scientific Information founded by Eugene Garfield, whose citation indexing evolved into the Science Citation Index. In 1992 the relevant assets became part of Thomson Corporation, later consolidated in Thomson Reuters after the 2008 merger with Reuters Group. In 2016, the intellectual property and science business was acquired by investors led by Onex Corporation and Baring Private Equity Asia and rebranded as Clarivate Analytics. The company went public on the New York Stock Exchange in 2019 via a reverse takeover involving Churchill Capital Corp II. Subsequent years featured rapid expansion through acquisitions and portfolio reorganizations, intersecting with entities such as ProQuest and historical brands like Derwent World Patents Index.
Clarivate is incorporated as a public limited company with dual headquarters in London and Philadelphia. The board of directors has included figures with backgrounds at BlackBerry, Autodesk, McKinsey & Company, and Goldman Sachs. Executive leadership has seen transitions from founders and private-equity appointees to public-company executives with experience at Elsevier, RELX Group, and ProQuest. Major governance interactions involve institutional investors such as BlackRock, Vanguard Group, and activist shareholders that have influenced strategic decisions and leadership appointments.
Clarivate operates multiple business units offering subscription databases, analytics platforms, and IP services. Flagship offerings include Web of Science, a citation and research discovery platform deriving from the Science Citation Index and used alongside bibliometric tools at University of Oxford, Stanford University, and University of Tokyo for research assessment. Derwent Innovation provides patent data and analytics used by patent attorneys at firms interacting with United States Patent and Trademark Office and European Patent Office. Cortellis offers pharmaceutical intelligence relied upon by teams at Johnson & Johnson, GlaxoSmithKline, and regulatory agencies like the U.S. Food and Drug Administration. EndNote is a reference management tool used across campuses such as Columbia University and University of Cambridge. Clarivate also provides trademark and brand protection services, competitive intelligence, and scholarly metrics such as Journal Citation Reports, impacting editorial decisions at publishers including Springer Nature, Wiley-Blackwell, Elsevier, and SAGE Publications.
Following the 2019 public listing, Clarivate’s financial profile has been shaped by revenue from subscriptions, licensing, and professional services, with notable debt incurred from acquisition financing backed by private-equity sponsors including Onex Corporation and Baring Private Equity Asia. Major shareholders have included asset managers such as BlackRock, Vanguard Group, and private-equity vehicles associated with the company’s founding consortium. Financial reporting to regulators like the U.S. Securities and Exchange Commission and listings on the New York Stock Exchange reflect metrics such as recurring revenue, adjusted EBITDA, and free cash flow, which investors use to evaluate performance against peers like RELX Group and Elsevier.
Clarivate’s growth strategy has relied on acquisitions: the 2016 carve-out from Thomson Reuters; the purchase of Publons to enhance peer-review and researcher profiles; the acquisition of ProQuest in 2021, expanding academic content and library services; and buys of specialized firms in patent analytics and regulatory intelligence. Divestitures and asset integrations have involved legacy Thomson products absorbed into Clarivate’s portfolios and occasional sales to niche providers. These transactions have connected Clarivate to marketplaces and legal frameworks involving Committee on Foreign Investment in the United States reviews and cross-border regulatory approvals with agencies in European Union member states.
Clarivate has faced scrutiny and disputes over antitrust concerns, pricing, and platform changes affecting libraries, universities, and publishers. The acquisition of ProQuest prompted examination by competition authorities in jurisdictions including United Kingdom and the European Commission. Customer dissatisfaction and library consortia such as Big Ten Academic Alliance and national library systems have publicly debated subscription terms and consolidation in scholarly infrastructure, often drawing commentary from organizations like the Association of Research Libraries and SPARC. Litigation matters have included contract disputes with corporate and academic clients and challenges related to intellectual property and data licensing.
Clarivate’s datasets and metrics, notably Web of Science and Journal Citation Reports, play central roles in bibliometrics, tenure and promotion evaluations at institutions such as Princeton University, Yale University, and University of California campuses, and in national research assessment exercises like the Research Excellence Framework in the United Kingdom and grant evaluation processes at agencies including National Science Foundation and European Research Council. Scholarly publishers, academic societies, and research funders engage with Clarivate’s indicators alongside alternatives from Scopus (operated by Elsevier), Google Scholar (by Google), and open initiatives promoted by CrossRef and OpenAIRE. The company’s influence on citation-based metrics, patent analytics, and competitive intelligence shapes strategic decisions across pharmaceutical, technology, and higher-education sectors.
Category:Information companies